March 15, 2011

Summit on fake and substandard drugs holds in Lagos

A talk shop on dangers of drug counterfeiting and the recent advances in the global anti-counterfeiting battle holds today at the Lagos Sheraton Hotel Ikeja, Lagos. Doctors, pharmacists and other healthcare professionals are expected at the event put together by Janssen-Cilag with support of its parent company, Johnson & Johnson of U.S.A.

Dignitaries expected include Director-General of National Agency for Food Drugs Administration and Control (NAFDAC), Dr Paul Orhii; President of the Pharmaceutical Society of Nigeria (PSN), Mr Azubike

Okwor and Director of Global Brand Protection of Johnson & Johnson and the Area General Manager of Janssen-Cilag, Near East/West Asia/African Territories.

Indeed, the problem of faking and adulteration of pharmaceutical products has been a major challenge to genuine pharmaceutical companies, regulatory agencies and healthcare practitioners in the country.

Mr Cliff Emenike Country Manager, Janssen-Cilag said, “As a way of protecting the interest of our patients, and supporting the efforts of the regulatory agencies, especially NAFDAC, Janssen-Cilag has put together this summit to highlight again the dangers of counterfeiting and the recent advances in the global anti-counterfeiting battle”.

High point of the event will be the presentation of Nizoral Tablet & Creams with an SMS-based anti-counterfeiting device supplied by Sproxil Inc.